Company: HVIIR
Filing Date: 2025-01-15
Form Type: S-1/A
Source: 0001493152-25-002259
Chunk: 99

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-01-15
Form: S-1/A
Chunk 99
---
 earned on the funds held in the trust account (which interest shall be net of permitted withdrawals and taxes payable), divided by the number of then outstanding public shares.

| 78 |

The issuance of additional ordinary shares or preference shares:

| ● | may                                                                     
 significantly dilute the equity interest of investors in this offering; |

| ● | may                                                                                                                                   
 subordinate the rights of holders of ordinary shares if preference shares is issued with rights senior to those afforded our ordinary 
 shares;                                                                                                                               |

| ● | could                                                                                                                                  
 cause a change of control if a substantial number of our ordinary shares are issued, which may affect, among other things, our ability 
 to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and       
 directors; and                                                                                                                         |

| ● | may                                                                                                   
 adversely affect prevailing market prices for our units, Class A ordinary shares and/or Share Rights. |

Our sponsor paid an aggregate of $25,000, or approximately $0.004 per founder share, and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class B ordinary shares.

The difference between the public offering price per share (allocating all of the unit purchase price to the Class A ordinary shares and none to the Share Rights included in the unit) and the pro forma net tangible book value per Class A ordinary share after this offering constitutes the dilution to you and the other investors in this offering. Our sponsor acquired the founder shares at a nominal price, significantly contributing to this dilution. Upon the closing of this offering, and assuming no value is ascribed to the Share Rights included in the units, you and the other public shareholders will incur an immediate and substantial dilution of approximately 97.18% (or $8.97 per share, assuming no exercise of the underwriters’ over-allotment option), the difference between the pro forma net tangible book deficit per share of $0.26 (assuming maximum redemption scenario) and the initial offering price of $9.23 per unit. In addition, because of the anti-dilution rights of the founder shares, any equity or equity-linked securities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A ordinary shares.

Holders of our founder shares will control the appointment of our board of directors until consummation of our initial business combination and will hold a substantial interest in us. As a result, they will appoint all of our directors prior to our initial